Literature DB >> 30450294

Extended pleurectomy decortication: the current role.

Rocco Bilancia1, Marco Nardini2, David A Waller3.   

Abstract

Extended pleurectomy/decortication (EPD) has been formally defined but there remain technical areas of debate between practitioners. This is partly attributable to the relative rarity of this operation which is largely confined to a small number of specialist centres. Nevertheless, there is a widespread acceptance that extended pleurectomy/decortication (P/D) is a realistic and favourable alternative to extrapleural pneumonectomy. There may, however, remain a small number of clinical cases where this more extensive operation may be indicated. Preservation of the lung has widened the selection criteria for this form of radical mesothelioma surgery but there remain important factors to consider when offering extended P/D. In many patients with poorer prognostic factors the less radical operation of video assisted partial pleurectomy may be preferable. However, a randomized trial showed no survival benefit for this operation over simple talc pleurodesis. The future for P/D may also lie in the outcome of the MARS2 randomized controlled trial which will report in the next few years. Meanwhile there is a clinical and ethical dilemma when asked to perform this operation outside of the context of a clinical trial in the face of the lack of high grade evidence. The role of P/D is in one respect expanding but this may be short lived pending the findings of its assessment against non-surgical treatment.

Entities:  

Keywords:  Pleural mesothelioma; pleurectomy/decortication (P/D); surgery

Year:  2018        PMID: 30450294      PMCID: PMC6204414          DOI: 10.21037/tlcr.2018.06.07

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN: 2218-6751


  33 in total

1.  Extrapleural pneumonectomy for early stage malignant pleural mesothelioma: a harmful procedure.

Authors:  Ottavio Rena; Caterina Casadio
Journal:  Lung Cancer       Date:  2012-01-11       Impact factor: 5.705

2.  The MARS feasibility trial: conclusions not supported by data.

Authors:  Walter Weder; Rolf A Stahel; Paul Baas; Urania Dafni; Marc de Perrot; Brian C McCaughan; Takashi Nakano; Harvey I Pass; Bruce W S Robinson; Valerie W Rusch; David J Sugarbaker; Nico van Zandwijk
Journal:  Lancet Oncol       Date:  2011-11       Impact factor: 41.316

3.  Pleurectomy/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma.

Authors:  Loïc Lang-Lazdunski; Andrea Bille; Rohit Lal; Paul Cane; Emma McLean; David Landau; Jeremy Steele; James Spicer
Journal:  J Thorac Oncol       Date:  2012-04       Impact factor: 15.609

Review 4.  Current Treatment of Mesothelioma: Extrapleural Pneumonectomy Versus Pleurectomy/Decortication.

Authors:  Andrea S Wolf; Raja M Flores
Journal:  Thorac Surg Clin       Date:  2016-08       Impact factor: 1.750

5.  Efficiency of fleece-bound sealing (TachoSil) of air leaks in lung surgery: a prospective randomised trial.

Authors:  Udo Anegg; Jörg Lindenmann; Veronika Matzi; Josef Smolle; Alfred Maier; Freyja Smolle-Jüttner
Journal:  Eur J Cardiothorac Surg       Date:  2006-12-21       Impact factor: 4.191

6.  The IASLC Mesothelioma Staging Project: Proposals for Revisions of the N Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma.

Authors:  David Rice; Kari Chansky; Anna Nowak; Harvey Pass; Hedy Kindler; Lynn Shemanski; Isabelle Opitz; Sergi Call; Seiki Hasegawa; Kemp Kernstine; Cansel Atinkaya; Federico Rea; Philippe Nafteux; Valerie W Rusch
Journal:  J Thorac Oncol       Date:  2016-09-26       Impact factor: 15.609

7.  Extrapleural pneumonectomy for malignant pleural mesothelioma: is this an operation that should now be consigned to history?

Authors:  Tom Treasure
Journal:  Future Oncol       Date:  2015       Impact factor: 3.404

8.  Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.

Authors:  Raja M Flores; Harvey I Pass; Venkatraman E Seshan; Joseph Dycoco; Maureen Zakowski; Michele Carbone; Manjit S Bains; Valerie W Rusch
Journal:  J Thorac Cardiovasc Surg       Date:  2008-02-14       Impact factor: 5.209

9.  How surgical care is changing in the technological era.

Authors:  Marcello Migliore
Journal:  Future Sci OA       Date:  2016-03-16

10.  Supplementary prognostic variables for pleural mesothelioma: a report from the IASLC staging committee.

Authors:  Harvey I Pass; Dorothy Giroux; Catherine Kennedy; Enrico Ruffini; Ayten K Cangir; David Rice; Hisao Asamura; David Waller; John Edwards; Walter Weder; Hans Hoffmann; Jan P van Meerbeeck; Valerie W Rusch
Journal:  J Thorac Oncol       Date:  2014-06       Impact factor: 15.609

View more
  1 in total

1.  Feasibility and safety of extended pleurectomy/decortication for malignant pleural mesothelioma. A single group experience.

Authors:  Francesco Falanga; Pietro Rinaldi; Cristiano Primiceri; Chandra Bortolotto; Olga Oneta; Francesco Agustoni; Patrizia Morbini; Laura Saracino; Dimitrios Eleftheriou; Federico Sottotetti; Giulia Maria Stella
Journal:  Thorac Cancer       Date:  2022-09-02       Impact factor: 3.223

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.